These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 4059475

  • 1. Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression.
    Extein I, Pottash AL, Gold MS.
    Psychoneuroendocrinology; 1985; 10(3):281-8. PubMed ID: 4059475
    [Abstract] [Full Text] [Related]

  • 2. Dexamethasone suppression test and sleep deprivation in endogenous depression.
    Kuhs H.
    J Affect Disord; 1985 Sep; 9(2):121-6. PubMed ID: 2932484
    [Abstract] [Full Text] [Related]

  • 3. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW, Wilens TE, Baldessarini RJ.
    Psychoneuroendocrinology; 1985 Sep; 10(1):49-60. PubMed ID: 4001277
    [Abstract] [Full Text] [Related]

  • 4. Abnormal pituitary function during melancholia: reduced alpha-melanocyte-stimulating hormone secretion and increased intact ACTH non-suppression.
    Maes M, DeJonckheere C, Vandervorst C, Schotte C, Cosyns P, Raus J, Suy E.
    J Affect Disord; 1991 Jul; 22(3):149-57. PubMed ID: 1655852
    [Abstract] [Full Text] [Related]

  • 5. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA, Fava GA, Perini GI, Molnar G, Zielezny M, Lisansky J.
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [Abstract] [Full Text] [Related]

  • 6. The dex/CRH test--is it better than the DST?
    Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH.
    Psychoneuroendocrinology; 2006 Aug; 31(7):889-94. PubMed ID: 16701957
    [Abstract] [Full Text] [Related]

  • 7. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
    Lemus CZ, Asnis GM, Halbreich U, Harkavy Friedman JM, Van Praag HM, Rubinson E, Eisenberg J.
    J Affect Disord; 1987 Aug; 12(3):219-21. PubMed ID: 2956306
    [Abstract] [Full Text] [Related]

  • 8. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
    Holsboer F, von Bardeleben U, Wiedemann K, Müller OA, Stalla GK.
    Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
    [No Abstract] [Full Text] [Related]

  • 9. Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol.
    Gerken A, Holsboer F.
    Psychoneuroendocrinology; 1986 Feb; 11(2):185-94. PubMed ID: 3018821
    [Abstract] [Full Text] [Related]

  • 10. Age and gender effects on the diagnostic power of the DST.
    Ansseau M, Depauw Y, Charles G, Castro P, D'Haenen H, De Vigne JP, Hubain P, Legros JJ, Pelc I, Toscano A.
    J Affect Disord; 1987 Feb; 12(3):185-91. PubMed ID: 2956303
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE, Stoll PM, Koslow SH, Maas JW, Davis JM, Swann AC, Robins E.
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [Abstract] [Full Text] [Related]

  • 12. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
    Bagdy G, Rihmer Z, Frecska E, Szádóczky E, Arató M.
    Psychoneuroendocrinology; 1986 Mar; 11(1):117-20. PubMed ID: 3704065
    [Abstract] [Full Text] [Related]

  • 13. Weekly monitoring of dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology.
    Gerken A, Maier W, Holsboer F.
    Psychoneuroendocrinology; 1985 Mar; 10(3):261-71. PubMed ID: 4059474
    [Abstract] [Full Text] [Related]

  • 14. [The dexamethasone suppression test in depression. Critical review].
    Bailly D, Goudemand M, Parquet PJ.
    Encephale; 1984 Mar; 10(4):155-69. PubMed ID: 6389093
    [Abstract] [Full Text] [Related]

  • 15. Dexamethasone suppression test in diagnosis of depressive illness.
    Hayes PE, Ettigi P.
    Clin Pharm; 1983 Mar; 2(6):538-45. PubMed ID: 6140096
    [Abstract] [Full Text] [Related]

  • 16. Major depressive episode and low dose dexamethasone suppression test.
    Sarai M, Taniguchi N, Kagomoto T, Kameda H, Uema T, Hishikawa Y.
    Folia Psychiatr Neurol Jpn; 1982 Mar; 36(2):109-14. PubMed ID: 7129257
    [Abstract] [Full Text] [Related]

  • 17. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G, Schifano F, De Leo D, De Dominicis MG, Garbin A, Zangaglia O.
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [Abstract] [Full Text] [Related]

  • 18. Nonsuppression of cortisol in depression and immune function.
    Syvälahti E, Eskola J, Ruuskanen O, Laine T.
    Prog Neuropsychopharmacol Biol Psychiatry; 1985 May; 9(4):413-22. PubMed ID: 4070644
    [Abstract] [Full Text] [Related]

  • 19. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
    Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
    Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252
    [Abstract] [Full Text] [Related]

  • 20. Repeated dexamethasone suppression test in depressed patients.
    Maes M, De Ruyter M, Hobin P, Suy E.
    J Affect Disord; 1986 Sep; 11(2):165-72. PubMed ID: 2948992
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.